Posted By Dr. Mercola | January 29 2012
Story at-a-glance
The CDC’s Advisory Committee on Immunization Practices now recommends Merck’s HPV vaccine, Gardasil, for males between the ages of 11 and 21
Gardasil is promoted for boys allegedly to offer partial protection against genital warts and cancers of the penis and rectum, and to reduce transmission of HPV to girls, thereby prevent cervical cancer deaths. The estimated cost to vaccinate 11- and 12-year old boys is $38 million
The HPV vaccine has NOT been proven to actually prevent cervical cancer. Likewise, after evaluating tissue changes in male genitalia that were suggestive of a cancer precursor, Merck reported that vaccine efficacy against such lesions “was not observed”
Cervical cancer accounts for less than ONE percent of all cancer deaths, and anal cancer strikes a mere 5,820 men and women each year. The annual death rate from anal cancer is 770 individuals—330 men and 470 women. Is the cost of this vaccination program truly worth it in light of the fact that we’re allegedly combating some of the LEAST concerning cancers with what’s been shown to be an unusually dangerous vaccine?
FULL STORY
No comments:
Post a Comment